| Form of release | Blister (25 tablets), Pack (100 tablets) |
|---|---|
| International Name | YK-11 |
| Chemical Name | (17α,20E)-17-hydroxy-3-oxo-4,17-dimethyl-5α-androst-20-en-19-yl acetate |
| Type of Drug Combination | SARM (selective androgen receptor modulator) |
| Molecular Formula | C25H34O6 |
| Molecular Weight | 430.54 g/mol |
| Halflife | 6–10 hours |
| Mechanism of Action | Activation of androgen receptors and suppression of myostatin expression (MSTN protein inhibitor) |
| Anabolic Activity | Very high |
| Androgenic Activity | Low |
| Main Effects | Increase in lean muscle mass, strength gains, accelerated recovery, reduction in myostatin levels |
| Side Effects | Testosterone suppression, aggression, hepatotoxicity, joint pain, hair loss |
| thenecessityofpct | Required |
| Recommended Dosage | 5–15 mg per day |
| Course Duration | 6–8 weeks |
| Reception Hours | In the morning and/or before training |
| Impact on Estrogens | No |
| Impact on the Liver | Moderate |
| Storage | In a dry, cool place, protected from light, at a temperature not exceeding 25°C |
| Use by Women | Not recommended due to high risk of virilization |
| Detection Period in the body | Up to 2 weeks |
